<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>ATROPINE SULFATE- atropine sulfateÂ ointmentÂ </strong><br>Bausch &amp; Lomb Incorporated<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1>
<span class="Bold">Atropine Sulfate Ophthalmic Ointment USP, 1% (Sterile)</span><br><br><span class="Bold">Rx only</span>
</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="i4i_description_id_518fbbbd-cefd-4ca3-a9b5-3ba6a23d1e25"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION:</h1>
<p class="First">Â Atropine Sulfate Ophthalmic Ointment USP, 1% is a sterile topical anticholinergic for ophthalmic use. The active ingredient is represented by the chemical structural formula:</p>
<div class="Figure">
<a name="id203"></a><img alt="Structural Formula" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c0a56d60-0914-42b1-af59-c56afe93d18c&amp;name=c0a56d60-0914-42b1-af59-c56afe93d18c-01.jpg">
</div>
<p>(C<span class="Sub">17</span>H<span class="Sub">23</span>NO<span class="Sub">3</span>)<span class="Sub">2</span>â€¢H<span class="Sub">2</span>SO<span class="Sub">4</span>â€¢H<span class="Sub">2</span>O   Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â <br>Mol. wt. 694.84</p>
<p><span class="Bold">Chemical name:</span></p>
<p>Benzeneacetic acid, Î±-(hydroxymethyl)-, 8-methyl-8-azabicyclo-(3.2.1)oct-3-yl ester, <span class="Italics">endo</span>-(Â±)-, sulfate (2:1) (salt), monohydrate.</p>
<p><span class="Bold">Each Gram Contains:</span></p>
<p>Atropine Sulfate Ophthalmic Ointment USP, 1%, contains in each gram of ointment: ACTIVE: Atropine Sulfate USP, 1% (10mg); INACTIVES: White Petrolatum, Mineral Oil, Lanolin Oil and Purified Water.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="i4i_clinical_pharmacology_id_62451cf7-a6eb-4464-af60-6c87a1a0967f"></a><a name="section-2"></a><p></p>
<h1>CHEMICAL PHARMACOLOGY:</h1>
<p class="First">The anticholinergic effect of this product blocks the responses of the sphincter muscle of the iris and the  accommodative muscle of the ciliary body to cholinergic stimulation, producing pupillary dilation (<span class="product-label-link" type="condition" conceptid="4290615" conceptname="Dilated pupil">mydriasis</span>) and <span class="product-label-link" type="condition" conceptid="440377" conceptname="Paralysis">paralysis</span> of accommodation (<span class="product-label-link" type="condition" conceptid="375263" conceptname="Cycloplegia">cycloplegia</span>).</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="i4i_indications_id_8eccd25d-ed1c-48ba-b720-6564a30b06da"></a><a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE:</h1>
<p class="First">For <span class="product-label-link" type="condition" conceptid="4290615" conceptname="Dilated pupil">mydriasis</span> and/or <span class="product-label-link" type="condition" conceptid="375263" conceptname="Cycloplegia">cycloplegia</span>. For cycloplegic refraction, for pupillary dilation desired in inflammatory conditions of the iris and uveal tract.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="i4i_contraindications_id_413e39a4-c289-4dbf-b84d-bcbb75bd0b36"></a><a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS:</h1>
<p class="First">This product should not be used in patients with primary <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span> or a predisposition to narrow anterior chamber angle <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span>.</p>
<p>This product should not be used in pediatric patients who have previously had a severe systemic reaction to atropine. This product should not be used in those persons showing <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any component of this preparation.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="i4i_warnings_id_154e46f4-7a75-4146-bcd7-89e6cd0ecd34"></a><a name="section-5"></a><p></p>
<h1>WARNINGS:</h1>
<p class="First">In pediatric patients, use with extreme caution. Excessive use in pediatric patients or in certain individuals with a previous history of susceptibility to belladonna alkaloids may produce systemic symptoms of atropine <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">poisoning</span>. If this occurs, discontinue medication, and use appropriate therapy as outlined in â€œ<a href="#i4i_overdosage_id_6009ae60-9197-485c-9243-f17123f324e2">OVERDOSAGE</a>â€? section.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="i4i_precautions_id_62b1b2ee-d9e4-425d-8b7e-fe491d9b8fea"></a><a name="section-6"></a><p></p>
<h1>PRECAUTIONS:</h1>
<p class="First">To avoid excessive systemic absorption, the lacrimal sac should be compressed by digital pressure for two to three minutes after instillation. To avoid inducing <span class="product-label-link" type="condition" conceptid="432312" conceptname="Chronic angle-closure glaucoma">angle closure glaucoma</span>, an estimation of the depth of the angle of the anterior chamber should be made. Administration of atropine in infants requires great caution.</p>
<div class="Section" data-sectionCode="34072-9">
<a name="i4i_precautions_general_id_6b6f5965-2dab-44be-b242-4f96904ace41"></a><a name="section-6.1"></a><p></p>
<h2>Patient Warning:</h2>
<p class="First">Patients should be advised not to drive or engage in other hazardous activities while pupils are dilated. Patients may experience sensitivity to light and should protect eyes in bright illumination during dilation.</p>
<p><br>Parents should be warned not to get this preparation in their childrenâ€™s mouth and to wash their own hands and the childâ€™s hands following administration.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="i4i_carcinogenesis_mutagenesis_fertility_id_c06ad78b-c5d0-409a-9431-63a09fd28860"></a><a name="section-6.2"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility:</h2>
<p class="First">No studies have been conducted in animals or in humans to evaluate the potential of these effects.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="i4i_pregnancy_id_8f613c1a-2fd8-4455-a6b8-e2fae0d7d0a7"></a><a name="section-6.3"></a><p></p>
<h2>Pregnancy Category C:</h2>
<p class="First">Animal reproduction studies have not been performed with atropine. It is also not known whether atropine can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Atropine should be given to pregnant women only if clearly needed.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="i4i_pediatric_use_id_3689583b-b8f4-40a8-a8af-815fb9d79dbf"></a><a name="section-6.4"></a><p></p>
<h2>Pediatric Use:</h2>
<p class="First">See "<a href="#i4i_contraindications_id_413e39a4-c289-4dbf-b84d-bcbb75bd0b36">CONTRAINDICATIONS</a>â€? and "<a href="#i4i_warnings_id_154e46f4-7a75-4146-bcd7-89e6cd0ecd34">WARNINGS</a>â€? sections.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="i4i_adverse_effects_id_22e295b4-887e-4c78-81c9-b339f5585732"></a><a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS:</h1>
<p class="First">Prolonged use may produce local irritation characterized by <span class="product-label-link" type="condition" conceptid="379019" conceptname="Conjunctivitis">follicular conjunctivitis</span>, vascular congestion, <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>, exudate, and an eczematoid <span class="product-label-link" type="condition" conceptid="133835" conceptname="Eczema">dermatitis</span>. Severe reactions are manifested by <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span> with progressive <span class="product-label-link" type="condition" conceptid="4214898" conceptname="Decreased respiratory function">respiratory depression</span>. <span class="product-label-link" type="condition" conceptid="380834" conceptname="Coma">Coma</span> and <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span> have been reported in the very young.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="i4i_overdosage_id_6009ae60-9197-485c-9243-f17123f324e2"></a><a name="section-8"></a><p></p>
<h1>OVERDOSAGE:</h1>
<p class="First">Systemic atropine toxicity is manifested by <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span> and dryness of the skin (a <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span> may be present in pediatric patients),<span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span>, a rapid and <span class="product-label-link" type="condition" conceptid="4088122" conceptname="Heart irregular">irregular pulse</span>, <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>, <span class="product-label-link" type="condition" conceptid="4218984" conceptname="Abdominal distension">abdominal distension</span> in infants, mental aberration (hallucinosis) and loss of neuromuscular coordination.</p>
<p><br>Atropine <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">poisoning</span>, although distressing, is rarely fatal, even with large doses of atropine, and is self-limited if the cause is recognized and the atropine medication is discontinued. In severe <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span>, physostigmine salicylate may be administered parenterally to provide more prompt relief of the <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span>. Give physostigmine salicylate as 1-5 mL IV of dilution containing 1 mg in 5 mL of saline. The smaller dose is for pediatric patients, and injection should take not less than two minutes. EKG control is advisable. Dosage can be repeated every five minutes up to a total dose of 2 mg in pediatric patients and 6 mg in adults every 30 minutes. Physostigmine is contraindicated in hypotensive reactions. Atropine (1 mg) should be available for immediate injection if physostigmine causes <span class="product-label-link" type="condition" conceptid="4169095" conceptname="Bradycardia">bradycardia</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span> or <span class="product-label-link" type="condition" conceptid="256717" conceptname="Bronchospasm">bronchoconstriction</span>. In pediatric patients, the body surface must be kept moist.</p>
<p><br>Use extreme caution when employing short-acting barbiturates to control <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">excitement</span>.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="i4i_dosage_admin_id_e7ddebe6-ece8-4a8c-b583-fffe92f37bf8"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION:</h1>
<p class="First">ATROPINE SULFATE OINTMENT: A small amount in the conjunctival sac once or twice a day or as directed by a physician.</p>
<p><br><span class="Bold">FOR OPHTHALMIC USE ONLY.</span></p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="i4i_how_supplied_id_496c6739-c06b-45a8-84a5-5efa215c6a2d"></a><a name="section-10"></a><p></p>
<h1>HOW SUPPLIED:</h1>
<p class="First">Atropine Sulfate Ophthalmic Ointment USP, 1% is supplied in an ophthalmic tip applicator tube in the following size:</p>
<p>3.5 gm tube - Prod. No. 05134</p>
<div class="Figure">
<a name="id356"></a><img alt="Image 1" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c0a56d60-0914-42b1-af59-c56afe93d18c&amp;name=c0a56d60-0914-42b1-af59-c56afe93d18c-02.jpg">
</div>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_cdd1ba6a-a9f6-4129-95c1-0717db4ce40a"></a><a name="section-11"></a><p></p>
<h1>STORAGE:</h1>
<p class="First">Store between 15Â°- 25Â°C (59Â°- 77Â°F).</p>
<p>KEEP OUT OF REACH OF CHILDREN.</p>
<p>Revised November 2007</p>
<p><span class="Bold">Bausch &amp; Lomb Incorporated</span><br>Tampa, FL 33637<br>Â© Bausch &amp; Lomb Incorporated</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="i4i_Principal_display_panel_id_75bdd50b-a496-4928-9ab6-75d6faa8ca4a"></a><a name="section-12"></a><p></p>
<h1>PACKAGE/LABEL PRINCIPAL DISPLAY PANEL</h1>
<div class="Figure">
<a name="id385"></a><img alt="Atropine Sulfate Carton" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c0a56d60-0914-42b1-af59-c56afe93d18c&amp;name=c0a56d60-0914-42b1-af59-c56afe93d18c-03.jpg">
</div>
<p class="First">NDC 24208-825-55</p>
<p>BAUSCH + LOMB</p>
<p>Atropine </p>
<p>Sulfate </p>
<p>Ophthalmic </p>
<p>Ointment USP, </p>
<p>1% (Sterile)</p>
<p>Rx only</p>
<p>[icon-eye] [icon-1%] [icon-ointment] [icon-3.5gm]</p>
<p>Net wt. 1/8 oz </p>
<p>(3.5g)</p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>ATROPINE SULFATEÂ 		
					</strong><br><span class="contentTableReg">atropine sulfate ointment</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:24208-825</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">OPHTHALMIC</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>ATROPINE SULFATE</strong> (ATROPINE) </td>
<td class="formItem">ATROPINE SULFATE</td>
<td class="formItem">10Â mg Â inÂ 1Â g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>PETROLATUM</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>MINERAL OIL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>LANOLIN OIL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:24208-825-55</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">3.5 g in 1 TUBE; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Unapproved drug other</td>
<td class="formItem"></td>
<td class="formItem">09/30/1990</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Bausch &amp; Lomb Incorporated
							(196603781)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Bausch &amp; Lomb Incorporated</td>
<td class="formItem"></td>
<td class="formItem">079587625</td>
<td class="formItem">MANUFACTURE(24208-825)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 1/2015<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>7541247b-c327-4473-9f70-a83723e3c5d4</div>
<div>Set id: c0a56d60-0914-42b1-af59-c56afe93d18c</div>
<div>Version: 3</div>
<div>Effective Time: 20150102</div>
</div>
</div>Â <div class="DistributorName">Bausch &amp; Lomb Incorporated</div></p>
</body></html>
